Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS)
- 21 October 2003
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 98 (1) , 73-78
- https://doi.org/10.1016/j.jinorgbio.2003.08.014
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour modelEuropean Journal Of Cancer, 2001
- Calculation of the Hydrophobicity of Platinum DrugsJournal of Medicinal Chemistry, 2000
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996
- Cytotoxicity, Accumulation, and Efflux of Cisplatin and Its Metabolites in Human Ovarian Carcinoma CellsToxicology and Applied Pharmacology, 1996
- Cellular distribution and cellular reactivity of platinum(II) complexesBiochemical Pharmacology, 1996
- Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomersCancer Letters, 1995
- Irradiation enhances cellular uptake of carboplatinInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Establishment and Characterization of Acquired Resistance to Platinum Anticancer Drugs in Human Ovarian Carcinoma CellsJapanese Journal of Cancer Research, 1995
- Measurement of protein using bicinchoninic acidAnalytical Biochemistry, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983